Article

Article detail, metadata, authors, and available full-text links.

Paper reader

Loading paper...

article · 2013

Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function in Adult Atypical Hemolytic Uremic Syndrome (aHUS) Patients (Pts)

9 citationsOpen accessPDF reported by metadataFull text reported by metadata

Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function in Adult Atypical Hemolytic Uremic Syndrome (aHUS) Patients (Pts)